This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Scadden, D. T. Articles by Howard, W. W. Search for Related Content PubMed PubMed Citation Articles by Scadden, D. T. Articles by Howard, W. W.

AIDS-Related Malignancies

AIDS Oncology Center, Massachusetts General Hospital, Dana-Farber/Partners Cancer Center, Harvard Medical School, Boston, Massachusetts, USA

Correspondence: David T. Scadden, M.D., AIDS Oncology Center, Massachusetts General Hospital, Dana-Farber/Partners Cancer Center, Harvard Medical School, 149 13th Street, Room 5212, Boston, Massachusetts 02129, USA. Telephone: 617-726-5615; Fax: 617-726-4691; e-mail: scadden.david{at}mgh.harvard.edu

The changing face of the AIDS epidemic since the introduction of protease inhibitors has had a significant impact on AIDS-related malignancies. These issues, emerging concepts regarding pathophysiology and current treatment strategies, are the subject of this review.

Key Words. AIDS • Non-Hodgkin's lymphoma • Kaposi's sarcoma • HIV-1 • AIDS-related lymphoma • Immunodeficiency